Mediantechn

ALMDT · PA · Healthcare / Medical Devices

4.36EUR+0.11 (+2.47%)

Price History

Full chart

Market Stats

Previous Close4.26

Open4.32

Day Range4.20 – 4.40

52-Week Range2.72 – 7.27

Volume148.47K

Market Cap158.28M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.93

Dividend Yield0.00%

Beta0.52

50-Day Avg4.12

200-Day Avg4.62

About

Median Technologies SA develops and markets software solutions and services for the use of medical images for the diagnosis and monitoring of patients with cancer in Europe, North America, and Asia. The company offers iCRO, an imaging service for oncology clinical trials; and eyonis, an end-to-end CADe/CADx software as medical devices. The company was founded in 2002 and is based in Valbonne, France.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Fredrik Brag
Employees199
Headquarters1800, Route des CrEtes, Valbonne, France, 06560, France
Websitehttps://mediantechnologies.com

Leadership

Mr. Fredrik BragFounder, GM, CEO & Director
Mr. Oran MudurogluPresident of Median eyonis Inc. & Chairman of the Board of Directors · b. 1963
Mr. Jean-Christophe MontignyChief Financial Officer · b. 1966
Ms. Emmanuelle LeyguesVice President of Corporate Marketing & Financial Communications
Ms. Chrystel BrunChief Human Resources Officer
Mr. Nicolas DanoChief Operating Officer & Chief Commercial Officer of iCRO
Mr. Thomas BonnefontChief Operating Officer & Chief Commercial Officer ? eyonis? Business Unit

Financials

Income Statement

Currency: EUR	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	1.45M	1.15M	1.15M	741.57K	886.07K	1.20M	3.28M	3.88M	6.35M	7.69M	6.34M	8.95M	13.48M	20.55M	23.67M	22.23M	22.95M	23.36M
Growth (%)	-	-20.60%	-0.54%	-35.24%	+19.48%	+35.74%	+172.88%	+18.37%	+63.55%	+20.96%	-17.51%	+41.18%	+50.58%	+52.45%	+15.20%	-6.10%	+3.25%	+1.79%
Cost of Revenue	7.14M	1.92M	1.28M	1.91M	39.56K	61.06K	4.40M	68.00K	109.00K	154.00K	131.00K	103.00K	135.00K	117.00K	-750.00K	24.78M	44.02M	-695.00K
Gross Profit	-5.69M	-768.13K	-136.17K	-1.17M	846.50K	1.14M	-1.12M	3.82M	6.25M	7.53M	6.21M	8.85M	13.34M	20.43M	24.42M	-2.55M	-21.07M	24.05M
Gross Margin	-392.15%	-66.71%	-11.89%	-157.78%	95.54%	94.92%	-34.00%	98.25%	98.28%	98.00%	97.93%	98.85%	99.00%	99.43%	103.17%	-11.48%	-91.82%	102.98%
Operating Expense	81.28K	3.56M	3.69M	2.99M	5.55M	5.73M	4.61M	9.50M	15.50M	24.61M	21.60M	16.74M	22.16M	32.02M	47.72M	20.57M	1.46M	39.99M
Operating Income	-5.77M	-4.33M	-3.83M	-4.16M	-4.71M	-4.59M	-5.72M	-5.68M	-9.26M	-17.08M	-15.39M	-7.89M	-8.82M	-11.60M	-23.30M	-23.12M	-22.53M	-15.94M
Operating Margin	-397.76%	-375.85%	-334.02%	-560.51%	-531.30%	-381.54%	-174.44%	-146.31%	-145.66%	-222.24%	-242.79%	-88.16%	-65.43%	-56.43%	-98.45%	-104.00%	-98.19%	-68.23%
EBITDA	-5.34M	-4.17M	-3.65M	-4.04M	-4.55M	-4.61M	-4.33M	-5.43M	-8.78M	-16.80M	-14.52M	-7.34M	-11.31M	-17.10M	-17.48M	-19.59M	-19.28M	-25.13M
EBITDA Margin	-368.27%	-362.27%	-319.07%	-544.76%	-513.37%	-383.40%	-131.87%	-139.77%	-138.18%	-218.62%	-229.07%	-82.06%	-83.90%	-83.23%	-73.83%	-88.12%	-84.01%	-107.60%
Net Income	-3.70M	-3.58M	-3.38M	-3.65M	-3.98M	-4.35M	-4.84M	-5.53M	-9.11M	-17.21M	-15.28M	-7.99M	-12.80M	-19.29M	-20.21M	-22.98M	-25.24M	-34.07M
Net Income Margin	-254.81%	-311.19%	-295.09%	-492.30%	-448.74%	-361.48%	-147.59%	-142.27%	-143.39%	-223.86%	-241.07%	-89.24%	-94.97%	-93.89%	-85.40%	-103.40%	-109.99%	-145.85%
R&D	3.86M	3.65M	-	-	2.89M	12.34K	2.66M	2.59M	3.21M	4.17M	5.31M	4.70M	4.43M	4.96M	5.01M	5.27M	-	-
R&D as % of Total Revenue	266.18%	317.17%	-	-	326.27%	1.03%	81.05%	66.69%	50.55%	54.31%	83.71%	52.49%	32.88%	24.16%	21.17%	23.69%	-	-
Interest Expense	405	82.31K	99.70K	297.51K	18.06K	11.53K	322.00K	15.00K	9.00K	3.00K	5.00K	94.00K	893.00K	1.35M	1.27M	2.10M	2.56M	17.66M
Interest Expense % of Total Revenue	0.03%	7.15%	8.71%	40.12%	2.04%	0.96%	9.81%	0.39%	0.14%	0.04%	0.08%	1.05%	6.63%	6.56%	5.39%	9.45%	11.17%	75.59%

Balance Sheet

Currency: EUR	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	5.83M	5.02M	4.67M	10.47M	488.41K	417.66K	17.87M	33.55M	46.55M	34.14M	18.15M	16.12M	25.28M	49.39M	34.75M	35.94M	24.37M	35.87M
Total Liabilities	1.46M	4.30M	7.33M	5.41M	488.41K	417.66K	4.09M	7.31M	7.82M	9.21M	9.05M	14.84M	36.65M	44.45M	42.01M	46.23M	58.34M	71.02M
Total Equity	3.63M	717.63K	-2.66M	5.06M	1.82M	-1.08M	13.78M	26.24M	38.74M	24.94M	9.09M	1.28M	-11.36M	4.94M	-7.25M	-10.29M	-33.97M	-35.15M
Cash	433.88K	209.73K	111.53K	7.83M	4.82M	2.07M	15.68M	30.27M	41.78M	28.29M	12.74M	7.62M	16.32M	39.01M	21.47M	19.51M	8.13M	18.25M
Total Debt	150.41K	1.19M	747.32K	90.41K	-	932.00K	782.00K	1.43M	459.00K	4.00K	3.00K	1.10M	20.18M	16.52M	18.15M	23.01M	29.44M	21.76M
Net Debt	-283.48K	982.71K	635.79K	-7.74M	-	-1.14M	-14.89M	-28.84M	-41.32M	-28.29M	-12.74M	-6.77M	-11.95M	-21.56M	-3.32M	3.51M	21.31M	3.52M

Cash Flow

Currency: EUR	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-4.42M	-3.41M	-3.76M	-7.57M	-13.85M	-15.64M	-4.39M	-5.46M	-10.13M	-15.79M	-20.24M	-17.95M	-17.43M
Investing Cash Flow	-48.00K	-57.00K	-433.00K	-506.00K	-503.00K	-98.00K	-195.00K	-327.00K	-672.00K	-1.39M	-1.25M	-1.17M	-824.00K
Financing Cash Flow	1.42M	17.07M	18.75M	19.57M	866.00K	189.00K	-543.00K	14.56M	33.20M	-277.00K	19.72M	7.67M	28.43M
Capital Expenditure	48.00K	57.00K	313.00K	477.00K	391.00K	255.00K	176.00K	359.00K	481.00K	1.39M	1.29M	1.08M	17.43M
Free Cash Flow	-4.46M	-3.46M	-4.08M	-8.05M	-14.24M	-15.90M	-4.56M	-5.82M	-10.61M	-17.18M	-21.53M	-19.03M	-18.17M
Dividends Paid	-	-	-	-	-	-	-	-	-	400.00K	-	-	-
FCF to OCF	101.09%	101.67%	108.32%	106.30%	102.82%	101.63%	104.01%	106.58%	104.75%	108.78%	106.39%	106.02%	104.29%
Dividend Paid to FCF	-	-	-	-	-	-	-	-	-	-2.33%	-	-	-

Earnings

Report Date	Feb 3, 2016	Oct 12, 2016	Apr 13, 2017	Oct 10, 2017	Apr 12, 2018	Oct 24, 2018	Apr 11, 2019	Oct 3, 2019	Apr 15, 2020	Oct 20, 2020	Apr 8, 2021	Oct 21, 2021	Apr 21, 2022	Oct 20, 2022	Apr 20, 2023	Oct 19, 2023	Apr 25, 2024	Oct 24, 2024	Apr 24, 2025	Oct 17, 2025
EPS Estimate	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	0.00	0.00	0.00	0.00	0.00
EPS Actual	-0.31	-0.36	-0.41	-0.76	-0.68	-0.75	-0.52	-0.35	-0.31	-0.38	-0.68	-0.65	-0.60	-0.57	-0.71	0.00	0.00	-0.68	-0.69	-0.47
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	-	-	-	-

Key Statistics & Ratios

Market Cap158.28M

Enterprise Value204.02M

Trailing P/E0.00

Forward P/E0.00

PEG Ratio0.00

Price / Sales6.74

Price / Book252.66

EPS-0.93

Book Value-0.957

Revenue (TTM)23.47M

Gross Profit (TTM)4.15M

EBITDA-14.10M

Profit Margin-145.17%

Operating Margin-57.75%

Return on Equity-511.28%

Return on Assets-33.75%

Shares Outstanding49.00M

Shares Float29.37M

Beta0.52

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%